BiomX Inc (PHGE) - Total Stockholders' Equity

The BiomX Inc. (PHGE) price chart demonstrates the dynamics of an asset with a value of 0.00. The business focuses on expanding the distribution of phage-based treatments within the hospital sector, where a chronic shortage persists. The brand's reputation is built on creating precision methods for combating pathogens. Risks are minimized through the development of therapies for the skin and lungs, which strengthens the company's position in the biotechnology industry.

This indicator reflects the current net asset value, recalculated based on market quotes to assess the issuer's actual financial reserve. By analyzing the company's capitalization on the balance sheet, an investor can track the equity dynamics of BiomX Inc. (PHGE), which, in the absence of operating revenue, depends directly on the efficiency of funding for bacteriophage clinical trials and the success of scientific developments.